| Product Name | MF | CAS | Details |
|---|
| CpCDPK1/TgCDPK1-IN-1 | C18H17N5 | 1092788-23-2 | Details |
| LSD1-IN-27 | C24H25N3 | 2904571-94-2 | Details |
| Tubulin polymerization-IN-43 | C17H13F4N3O | 2773345-90-5 | Details |
| Tubulin polymerization-IN-55 | C22H24N2O4 | 2942396-29-2 | Details |
| SARS-CoV-2 3CLpro-IN-16 | C17H14N2OS | 352659-40-6 | Details |
| ADS032 | C22H29NO4S | 2757333-37-0 | Details |
| Trontinemab | 2568868-35-7 | Details |
| Antiviral agent 34 | 945152-88-5 | Details |
| Zharp2-1 | C19H18N3O2PS | 2772600-18-5 | Details |
| S5A1 | C27H33N3O4.ClH | 2055882-51-2 | Details |
| 3,5,6-trihydroxysitostane | C29H52O3 | 133697-68-4 | Details |
| JG-2016 | C18H21ClN4O3 | 2887480-87-5 | Details |
| IDH2R140Q-IN-2 | 2749568-16-7 | Details |
| Clozapine Analogues | 124380-97-8 | Details |
| Aprocitentan | C16H14Br2N6O4S | 1103522-45-7 | Details |
| a-MSH, amide Acetate(581-05-5 free base) | C77H109N21O19S | 581-05-5 | Details |
| Nrf2 activator-3 | C23H18F3N3O2 | 2766570-23-2 | Details |
| MY-1076 | C29H33NO9 | 3008262-76-5 | Details |
| D4R agonist-1 | 2826198-44-9 | Details |
| TIE-2/VEGFR-2 kinase-IN-5 | 1014407-83-0 | Details |
| LCC-12 FA | 3029253-76-4 | Details |
| AVN 322 free base | C17H19N5O2S | 1194574-33-8 | Details |
| EBOV-IN-1 | C34H43N3O5 | 1335113-30-8 | Details |
| Enpp-1-IN-16 | C23H32N4O4 | 2289739-47-3 | Details |
| h-NTPDase-IN-3 | 2939933-10-3 | Details |
| IR820-PTX | 2250419-19-1 | Details |
| 3,3'-Selenobisalanine | 61216-56-6 | Details |
| VUN65671 | C25H30F3N3O2 | 2479465-67-1 | Details |
| Ipamorelin 2 Pivalic acid | C38H49N9O5 | 170851-70-4 | Details |
| Cloroperone | C22H23ClFNO2 | 61764-61-2 | Details |
| KSK94 | 2566716-07-0 | Details |
| Z16078526 | C18H17N3O4S | 852222-94-7 | Details |
| LW3 | C17H12F3N3O | 2803367-68-0 | Details |
| Aneratrigine hydrochloride | 2097163-75-0 | Details |
| mTOR kinase Inhibitor 1 | C20H27N7O5 | 321557-16-8 | Details |
| AST 7062601 | C18H15N3O4S | 675197-89-4 | Details |
| IRG1-IN-1 | C18H15FO4 | 2407652-42-8 | Details |
| VU534 | C21H22FN3O3S2 | 923509-20-0 | Details |
| KSK68 | 2566715-91-9 | Details |
| AKE-72 | C30H29F3N6O | 2566525-18-4 | Details |
| OPC18750 HCl | 145364-90-5 | Details |
| 1H-Indole, 3,3'-(2-thienylmethylene)bis[2-methyl- | C23H20N2S | 138801-72-6 | Details |
| Tenilapine | 82650-83-7 | Details |
| CC214-1 | C20H21N7O2 | 1021920-32-0 | Details |
| (1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid | C16H23N3O2.C4H6O6 | 2919211-45-1 | Details |
| AS601245.2TFA (345987-15-7 free base) | C20H16N6S.2C2HF3O2 | 345987-16-8 | Details |
| (S)-OSMI 3 | 2411972-78-4 | Details |
| CI 169369 | C19H21ClN2S | 85273-96-7 | Details |
| (R)-Monepantel | C20H13F6N3O2S | 887148-70-1 | Details |
| Lingdolinurad | C17H12BrN3O2 | 2088176-96-7 | Details |
| B-Raf IN 16 | C20H19N5O3S | 2304746-24-3 | Details |
| IMMH 010 maleate | C36H36BrClN2O9 | 2541982-47-0 | Details |
| TNF/IFNγ-IN-1 | C20H23N3O6 | 876013-29-5 | Details |
| Antimalarial agent 30 | 1597425-64-3 | Details |
| Relenopride | C24H30ClFN4O4 | 1221416-43-8 | Details |
| LFHP-1c | C55H64N6O4 | 2102347-47-5 | Details |
| BIIB 722 Mesylate | C19H23F3N6O5S | 261505-81-1 | Details |
| MMP-9-IN-6 | C25H19NO2 | 2241964-36-1 | Details |
| EGFR-IN-87 | C28H33N7O2 | 1835666-87-9 | Details |
| (S)-VB 201 | 936227-77-9 | Details |
| Topoisomerase II inhibitor 14 | C15H11Cl2N5 | 305343-00-4 | Details |
| Fenclozine Maleate | C45H47ClN2O12 | 76823-82-0 | Details |
| Tubulin inhibitor 32 | 2923531-39-7 | Details |
| PI3Kδ-IN-16 | C22H26N6O2 | 2766437-35-6 | Details |
| QST4 | C16H13ClN4O2S2 | 2991427-35-9 | Details |
| Anti-inflammatory agent 49 | C21H22N8O3S | 851471-44-8 | Details |
| Estrogen receptor antagonist 8 | 2889370-92-5 | Details |
| (Z)-Tenilapine | 82650-82-6 | Details |
| Safingol hydrochloride | C18H39NO2. HCl | 139755-79-6 | Details |
| JHU 75528 | C23H21Cl2N5O2 | 947696-17-5 | Details |
| Phosphatase-IN-1 | 2889356-55-0 | Details |
| DHX9-IN-2 | C18H16ClN3O3S2 | 2973395-71-8 | Details |
| TIM-3-IN-2 | C25H23N3O6 | 1113126-49-0 | Details |
| 20-HETE Intermediate 15 | C23H36O4 | 1286736-37-5 | Details |
| SQLE-IN-1 | C24H21F2N5O2S | 1019169-83-5 | Details |
| LSD1-IN-30 | C15H14N2O3 | 1289575-45-6 | Details |
| MC4033 | C16H13N3O3 | 28532-21-0 | Details |
| CCG-13514 | C25H25BrN2O2 | 423741-32-6 | Details |
| NSC 122393 | C20 H8 Br4 O5 | 73654-97-4 | Details |
| mTOR inhibitor 13 | C24H22N6O2S | 1144075-44-4 | Details |
| A09-003 | 2911646-14-3 | Details |
| Sulcardine 2HCl | 343935-48-8 | Details |
| RN-1665 | C20H24F5N3O3S2 | 1803003-65-7 | Details |
| MM0299 | C26H23NO5 | 474255-10-2 | Details |
| Ogremorphin | C21H17N3OS | 352563-21-4 | Details |
| mTOR kinase Inhibitor 2 | C19H23N5O3 | 1021917-65-6 | Details |
| EGFR/ErbB-2 inhibitor-1 | 1135150-79-6 | Details |
| SARS-CoV-2-IN-38 | 2882823-27-8 | Details |
| DJ4 | C19H16N4OS | 1681020-24-5 | Details |
| h-NTPDase-IN-2 | 2939933-03-4 | Details |
| AMPK activator 12 | C23H24BrNO2 | 431920-24-0 | Details |
| ALK-IN-26 | C24H23NO3S | 2447607-85-2 | Details |
| Usenamine A | C18H17NO6 | 1428417-60-0 | Details |
| MoTPS1-IN-1 | C23H27F3N2O4 | 2991072-02-5 | Details |
| PLpro/RBD-IN-1 | C13H10N4O | 1282451-83-5 | Details |
| 1-N-Methyl-4-mercaptohistidine disulfide | 73491-33-5 | Details |
| OX04528 | C16H13F6NO2 | 3028055-45-7 | Details |
| XPW1 | C36H39ClFN7O2 | 2700286-66-2 | Details |
| PAC1R antagonist 1 | C17H17ClN6O2 | 2305204-24-2 | Details |
| AC-099 hydrochloride | C9H9Cl2F3N4 | 849335-07-5 | Details |
| Product Total： Product Page： | ||||
| 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 | ||||